SDC1 and Miyoshi myopathy: Multiple myeloma (MM) cells exposed to doxorubicin exhibit reduced CD138 expression and increased CD45/CD20 levels, hallmarks of MM stemness, correlating with the upregulation of SASP factors, particularly RANTES.